Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Ophthalmological Medicine
Volume 2013, Article ID 591681, 8 pages
http://dx.doi.org/10.1155/2013/591681
Case Report

Intravitreal and Subtenon Depot Triamcinolone as Treatment of Retinitis Pigmentosa Associated Cystoid Macular Edema

Department of Ophthalmology, Vila Nova Gaia/Espinho Hospital, Rua Conceição Fernandes, 4434-502 Vila Nova Gaia, Portugal

Received 14 September 2013; Accepted 25 November 2013

Academic Editors: M. B. Parodi and P. Venkatesh

Copyright © 2013 Sidnei Barge et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. F. Marmor, G. Aguirre, and G. Arden, “Retinitis pigmentosa. A symposium on terminology and methods of examination,” Ophthalmology, vol. 90, no. 2, pp. 126–131, 1983. View at Google Scholar · View at Scopus
  2. H. Ozdemir, M. Karacorlu, and S. Karacorlu, “Intravitreal triamcinolone acetonide for treatment of cystoid macular oedema in patients with retinitis pigmentosa,” Acta Ophthalmologica Scandinavica, vol. 83, no. 2, pp. 248–251, 2005. View at Publisher · View at Google Scholar · View at Scopus
  3. G. A. Fishman, A. M. Glenn, and L. D. Gilbert, “Rebound of macular edema with continued use of methazolamide in patients with retinitis pigmentosa,” Archives of Ophthalmology, vol. 111, no. 12, pp. 1640–1646, 1993. View at Google Scholar · View at Scopus
  4. G. A. Fishman, J. M. Maggiano, and M. Fishman, “Foveal lesions seen in retinitis pigmentosa,” Archives of Ophthalmology, vol. 95, no. 11, pp. 1993–1996, 1977. View at Google Scholar · View at Scopus
  5. B. Moldow, B. Sander, M. Larsen et al., “The effect of acetazolamide on passive and active transport of fluorescein across the blood-retina barrier in retinitis pigmentosa complicated by macular oedema,” Graefe's Archive for Clinical and Experimental Ophthalmology, vol. 236, no. 12, pp. 881–889, 1998. View at Publisher · View at Google Scholar · View at Scopus
  6. C. Giusti, R. Forte, and E. M. Vingolo, “Deflazacort treatment of cystoid macular edema in patients affected by Retinitis Pigmentosa: a pilot study,” European Review for Medical and Pharmacological Sciences, vol. 6, no. 1, pp. 1–8, 2002. View at Google Scholar · View at Scopus
  7. J. García-Arurmí, V. Martinez, L. Sararols, and B. Corcostegui, “Vitreoretinal surgery for cystoid macular edema associated with retinitis pigmentosa,” Ophthalmology, vol. 110, no. 6, pp. 1164–1169, 2003. View at Publisher · View at Google Scholar · View at Scopus
  8. G. A. Fishman, L. D. Gilbert, R. G. Fiscella, A. E. Kimura, and L. M. Jampol, “Acetazolamide for treatment of chronic macular edema in retinitis pigmentosa,” Archives of Ophthalmology, vol. 107, no. 10, pp. 1445–1452, 1989. View at Google Scholar · View at Scopus
  9. D. A. Newsome and P. A. Blacharski, “Grid photocoagulation for macular edema in patients with retinitis pigmentosa,” American Journal of Ophthalmology, vol. 103, no. 2, pp. 161–166, 1987. View at Google Scholar · View at Scopus
  10. C. Hamel, “Retinitis pigmentosa,” Orphanet Journal of Rare Diseases, vol. 1, no. 1, article 40, pp. 687–693, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. G. Querques, F. Prascina, C. Iaculli, and N. D. Noci, “Intravitreal pegaptanib sodium (Macugen) for refractory cystoid macular edema in pericentral retinitis pigmentosa,” International Ophthalmology, vol. 29, no. 2, pp. 103–107, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. H. Hirakawa, H. Iijima, T. Gohdo, and S. Tsukahara, “Optical coherence tomography of cystoid macular edema associated with retinitis pigmentosa,” American Journal of Ophthalmology, vol. 128, no. 2, pp. 185–191, 1999. View at Publisher · View at Google Scholar · View at Scopus
  13. P. E. Stanga, S. M. Downes, R. M. Ahuja et al., “Comparison of optical coherence tomography and fluorescein angiography in assessing macular edema in retinal dystrophies: preliminary results,” International Ophthalmology, vol. 23, no. 4-6, pp. 321–325, 2001. View at Publisher · View at Google Scholar · View at Scopus
  14. M. A. Apushkin, G. A. Fishman, and M. J. Janowicz, “Monitoring cystoid macular edema by optical coherence tomography in patients with retinitis pigmentosa,” Ophthalmology, vol. 111, no. 10, pp. 1899–1904, 2004. View at Publisher · View at Google Scholar · View at Scopus
  15. W. A. Baumgartner, “Etiology, pathogenesis, and experimental treatment of retinitis pigmentosa,” Medical Hypotheses, vol. 54, no. 5, pp. 814–824, 2000. View at Publisher · View at Google Scholar · View at Scopus
  16. R. Adler, “Mechanisms of photoreceptor death in retinal degenerations: from the cell biology of the 1990s to the ophthalmology of the 21st century?” Archives of Ophthalmology, vol. 114, no. 1, pp. 79–83, 1996. View at Google Scholar · View at Scopus
  17. A. C. Bird, “Investigation of disease mechanisms in retinitis pigmentosa,” Ophthalmic Paediatrics and Genetics, vol. 13, no. 2, pp. 57–66, 1992. View at Google Scholar · View at Scopus
  18. V. S. Saraiva, J. M. F. Sallum, and M. E. Farah, “Treatment of cystoid macular edema related to retinitis pigmentosa with intravitreal triamcinolone acetonide,” Ophthalmic Surgery Lasers and Imaging, vol. 34, no. 5, pp. 398–400, 2003. View at Google Scholar · View at Scopus
  19. G. B. Melo, M. E. Farah, and F. B. Aggio, “Intravitreal injection of bevacizumab for cystoid macular edema in retinitis pigmentosa,” Acta ophthalmologica Scandinavica, vol. 85, no. 4, pp. 461–463, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. S. A. Vinores, N. L. Derevjanik, H. Ozaki, N. Okamoto, and P. A. Campochiaro, “Cellular mechanisms of blood-retinal barrier dysfunction in macular edema,” Documenta Ophthalmologica, vol. 97, no. 3-4, pp. 217–228, 1999. View at Google Scholar · View at Scopus
  21. J. B. Jonas, I. Akkoyun, B. Kamppeter, I. Kreissig, and R. F. Degenring, “Branch retinal vein occlusion treated by intravitreal triamcinolone acetonide,” Eye, vol. 19, no. 1, pp. 65–71, 2005. View at Publisher · View at Google Scholar · View at Scopus
  22. F. Batioǧlu, E. Özmert, N. Parmak, and S. Çelik, “Two-year results of intravitreal triamcinolone acetonide injection for the treatment of diabetic macular edema,” International Ophthalmology, vol. 27, no. 5, pp. 299–306, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. M. A. Sandberg, R. J. Brockhurst, A. R. Gaudio, and E. L. Berson, “The association between visual acuity and central retinal thickness in retinitis pigmentosa,” Investigative Ophthalmology and Visual Science, vol. 46, no. 9, pp. 3349–3354, 2005. View at Publisher · View at Google Scholar · View at Scopus
  24. J. R. Heckenlively, A. M. Solish, S. M. Chant, and R. H. Meyers-Elliott, “Autoimmunity in hereditary retinal degenerations. II. Clinical studies: antiretinal antibodies and fluorescein angiogram findings,” British Journal of Ophthalmology, vol. 69, no. 10, pp. 758–764, 1985. View at Google Scholar · View at Scopus
  25. S. N. Cox, E. Hay, and A. C. Bird, “Treatment of chronic macular edema with acetazolamide,” Archives of Ophthalmology, vol. 106, no. 9, pp. 1190–1195, 1988. View at Google Scholar · View at Scopus
  26. S. Grover, M. A. Apushkin, and G. A. Fishman, “Topical dorzolamide for the treatment of cystoid macular edema in patients with retinitis pigmentosa,” American Journal of Ophthalmology, vol. 141, no. 5, pp. 850–858, 2006. View at Publisher · View at Google Scholar · View at Scopus
  27. F. L. Kiechle, T. M. Quattrociocchi-Longe, and D. A. Brinton, “Carbonic anhydrase antibody in sera from patients with endometriosis,” American Journal of Clinical Pathology, vol. 101, no. 5, pp. 611–615, 1994. View at Google Scholar · View at Scopus
  28. J. R. Heckenlively, B. L. Jordan, and N. Aptsiauri, “Association of antiretinal antibodies and cystoid macular edema in patients with retinitis pigmentosa,” American Journal of Ophthalmology, vol. 127, no. 5, pp. 565–573, 1999. View at Publisher · View at Google Scholar · View at Scopus
  29. T. J. Wolfensberger, N. Aptsiauri, B. Godley, S. Downes, and A. C. Bird, “Antiretinal antibodies and macular oedema,” Klinische Monatsblatter für Augenheilkunde, vol. 216, no. 5, pp. 283–285, 2000. View at Publisher · View at Google Scholar · View at Scopus
  30. J. B. Jonas, J. K. Hayler, A. Söfker, and S. Panda-Jonas, “Intravitreal injection of crystalline cortisone as adjunctive treatment of proliferative diabetic retinopathy,” American Journal of Ophthalmology, vol. 131, no. 4, pp. 468–471, 2001. View at Publisher · View at Google Scholar · View at Scopus
  31. D. M. Moshfeghi, P. K. Kaiser, I. U. Scott et al., “Acute endophthalmitis following intravitreal triamcinolone acetonide injection,” American Journal of Ophthalmology, vol. 136, no. 5, pp. 791–796, 2003. View at Publisher · View at Google Scholar · View at Scopus
  32. D. B. Roth, J. Chieh, M. J. Spirn, S. N. Green, D. L. Yarian, and N. A. Chaudhry, “Noninfectious endophthalmitis associated with intravitreal triamcinolone injection,” Archives of Ophthalmology, vol. 121, no. 9, pp. 1279–1282, 2003. View at Publisher · View at Google Scholar · View at Scopus
  33. P. L. Penfold, L. Wen, M. C. Madigan, M. C. Gillies, N. J. C. King, and J. M. Provis, “Triamcinolone acetonide modulates permeability and intercellular adhesion molecule-1 (ICAM-1) expression of the ECV304 cell line: implications for macular degeneration,” Clinical and Experimental Immunology, vol. 121, no. 3, pp. 458–465, 2000. View at Publisher · View at Google Scholar · View at Scopus
  34. M. Hajali, G. A. Fishman, and R. J. Anderson, “The prevalence of cystoid macular oedema in retinitis pigmentosa patients determined by optical coherence tomography,” British Journal of Ophthalmology, vol. 92, no. 8, pp. 1065–1068, 2008. View at Publisher · View at Google Scholar · View at Scopus
  35. S. Grover, G. A. Fishman, R. G. Fiscella, and A. E. Adelman, “Efficacy of dorzolamide hydrochloride in the management of chronic cystoid macular edema in patients with retinitis pigmentosa,” Retina, vol. 17, no. 3, pp. 222–231, 1997. View at Google Scholar · View at Scopus
  36. E. L. Berson, M. A. Sandberg, and B. Rosner, “Natural course of retinitis pigmentosa over a three-year interval,” American Journal of Ophthalmology, vol. 99, no. 3, pp. 240–251, 1985. View at Google Scholar · View at Scopus
  37. S. Grover, G. A. Fishman, L. D. Gilbert, and R. J. Anderson, “Reproducibility of visual acuity measurements in patients with retinitis pigmentosa,” Retina, vol. 17, no. 1, pp. 33–37, 1997. View at Google Scholar · View at Scopus
  38. P. Massin, E. Vicaut, B. Haouchine, A. Erginay, M. Paques, and A. Gaudric, “Reproducibility of retinal mapping using optical coherence tomography,” Archives of Ophthalmology, vol. 119, no. 8, pp. 1135–1142, 2001. View at Google Scholar · View at Scopus
  39. V. C. Greenstein, K. Holopigian, E. Siderides, W. Seiple, and R. E. Carr, “The effects of acetazolamide on visual function in retinitis pigmentosa,” Investigative Ophthalmology and Visual Science, vol. 34, no. 1, pp. 269–273, 1993. View at Google Scholar · View at Scopus
  40. J. B. Jonas, “Intraocular availability of triamcinolone acetonide after intravitreal injection,” American Journal of Ophthalmology, vol. 137, no. 3, pp. 560–562, 2004. View at Publisher · View at Google Scholar · View at Scopus